IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
0.740
-0.080 (-9.78%)
At close: Nov 7, 2024, 4:00 PM
0.810
+0.070 (9.49%)
After-hours: Nov 7, 2024, 7:20 PM EST

IceCure Medical Revenue

IceCure Medical had revenue of $1.01M in the quarter ending June 30, 2024, with 7.90% growth. This brings the company's revenue in the last twelve months to $3.34M, up 3.60% year-over-year. In the year 2023, IceCure Medical had annual revenue of $3.23M with 4.67% growth.

Revenue (ttm)
$3.34M
Revenue Growth
+3.60%
P/S Ratio
11.49
Revenue / Employee
$43,325
Employees
77
Market Cap
36.64M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20233.23M144.00K4.67%
Dec 31, 20223.09M-1.05M-25.45%
Dec 31, 20214.14M270.00K6.98%
Dec 31, 20203.87M-1.87M-32.61%
Dec 31, 20195.74M1.70M42.18%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
NeueHealth 1.03B
LakeShore Biopharma 79.42M
Exagen 56.66M
Apyx Medical 49.03M
ProPhase Labs 17.97M
DURECT 8.41M
CollPlant Biotechnologies 689.00K
Lexaria Bioscience 411.02K
Revenue Rankings